AMRX logo

Amneal Pharmaceuticals, Inc. (AMRX) Long term liabilities

Annual long term liabilities:

N/A
December 31, 2024

Summary

  • AMRX annual total long term liabilities is not available.

Performance

AMRX Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherAMRXbalance sheet metrics

quarterly long term liabilities:

$2.43B+$79.37M(+3.38%)
June 30, 2025

Summary

  • As of today (August 16, 2025), AMRX quarterly total long term liabilities is $2.43 billion, with the most recent change of +$79.37 million (+3.38%) on June 30, 2025.
  • Over the past year, AMRX quarterly long term liabilities has increased by +$28.55 million (+1.19%).
  • AMRX quarterly long term liabilities is now -19.88% below its all-time high of $3.03 billion, reached on June 30, 2020.

Performance

AMRX quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

AMRX Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+1.2%
3 y3 years--15.0%
5 y5 years--19.9%

AMRX Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-15.2%+3.4%
5 y5-year-19.9%+3.4%
alltimeall time-19.9%+70.9%

AMRX Long term liabilities History

DateAnnualQuarterly
Jun 2025
-
$2.43B(+3.4%)
Mar 2025
-
$2.35B(-5.3%)
Dec 2024
-
$2.48B(+3.4%)
Sep 2024
-
$2.40B(-0.0%)
Jun 2024
-
$2.40B(-9.1%)
Mar 2024
-
$2.64B(+1.3%)
Dec 2023
-
$2.61B(-4.7%)
Sep 2023
-
$2.74B(-0.2%)
Jun 2023
-
$2.74B(-0.7%)
Mar 2023
-
$2.76B(-3.6%)
Dec 2022
-
$2.86B(+0.8%)
Sep 2022
-
$2.84B(-0.6%)
Jun 2022
-
$2.86B(-0.8%)
Mar 2022
-
$2.88B(-0.6%)
Dec 2021
-
$2.90B(-1.0%)
Sep 2021
-
$2.92B(-1.2%)
Jun 2021
-
$2.96B(+0.1%)
Mar 2021
-
$2.96B(-0.9%)
DateAnnualQuarterly
Dec 2020
-
$2.98B(-1.2%)
Sep 2020
-
$3.02B(-0.3%)
Jun 2020
-
$3.03B(+0.3%)
Mar 2020
-
$3.02B(+9.2%)
Dec 2019
$39.58M(-83.0%)
$2.77B(-0.2%)
Sep 2019
-
$2.77B(-6.5%)
Jun 2019
-
$2.97B(-0.6%)
Mar 2019
-
$2.99B(+2.9%)
Dec 2018
$232.84M(+819.3%)
$2.90B(-0.5%)
Sep 2018
-
$2.92B(-0.6%)
Jun 2018
-
$2.94B(+106.6%)
Dec 2017
$25.33M(-76.7%)
$1.42B
Dec 2015
$108.72M(+222.5%)
-
Dec 2014
$33.71M(-5.0%)
-
Dec 2013
$35.49M(-87.2%)
-
Dec 2009
$277.15M(+48.4%)
-
Dec 2008
$186.77M(+21.7%)
-
Dec 2007
$153.49M(+56.6%)
-
Dec 2005
$98.03M
-

FAQ

  • What is the all time high annual long term liabilities for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?

What is the all time high annual long term liabilities for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high annual total long term liabilities is $277.15M

What is Amneal Pharmaceuticals, Inc. quarterly total long term liabilities?

The current quarterly long term liabilities of AMRX is $2.43B

What is the all time high quarterly long term liabilities for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high quarterly total long term liabilities is $3.03B

What is Amneal Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?

Over the past year, AMRX quarterly total long term liabilities has changed by +$28.55M (+1.19%)
On this page